Inc. Magazine Names Clinipace Worldwide to the Inc. 500 Annual List of America’s Fastest-Growing Private Companies
Exclusive Ranking Demonstrates Market Adoption of Technology-Amplified Service Delivery and a True Testament to Employee Hard Work and Customer Loyalty
(BusinessWire) –Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that it has been named to Inc. Magazine’s 29th annual Inc. 500, an exclusive ranking of the nation’s fastest-growing private companies. Ranked 485, Clinipace is listed among the most successful private companies that have experienced substantial revenue growth over a three year period (2006-2009).
A celebration of innovation, the Inc. 500 recognition confirms that Clinipace Worldwide is changing the face of global life science clinical research and development through its technology-amplified approach to conducting and managing clinical trials. Since its inception, the company has transformed clinical research by merging a proprietary technology platform with expert services – defining a new category of research organization – the digital CRO, or dCRO. The company is guided by the philosophy that technology is not an add-on to clinical trial processes; it is the backbone on which expert services are built.
A real demand exists for transparent and fully-integrated clinical research solutions among mid-tier biopharmaceutical and medical device firms, as proven by Clinipace Worldwide’s triple-digit growth over the past 12 months. Revenue exploded 614% over the past three years and the company expects 2010 revenues to more than double over 2009.
Although the current shift occurring in clinical research is fueled by technology, the people behind the services are the lifeblood of the transformation. Clinipace’s impressive growth could not have been possible without the dedication of its stellar employees and their strong commitment to superior customer service and support. A devoted customer base challenges Clinipace to not only meet, but exceed expectations.
“Over the past three years the notion of technology as an enabler for service delivery has gone from an afterthought to a must-have for creating efficient clinical research processes,” said Jeff Williams, Chairman and CEO, Clinipace Worldwide. “Proactive clinical trial management ensures a successful clinical development program from start to finish. This could not be done without the dedication and tireless efforts of our employees across the globe, as well as the commitment from our loyal customer base. We are thankful to all who have how to order tramadol from mexico worked towards this success.”
This year’s winners will be honored at the 29th Annual Inc. 500|5000 Conference and Awards Ceremony September 30 to October 2, 2010, at the Gaylord National Resort and Convention Center in Washington, D.C.
About Inc. 500|5000 List
In 1982, Inc. introduced the Inc. 500 list of the fastest-growing privately held companies in the United States. Since then, this prestigious list of the nation’s most successful private companies has become the hallmark of entrepreneurial success and the place where future household names first make their mark. Oracle, Patagonia, E*Trade, American Apparel, Zipcar and numerous other well-known brands have been honored by the Inc. 500|5000. In 2007, the Inc. 500 list expanded to the Inc. 500|5000, giving readers a deeper, richer understanding of the entrepreneurial landscape and capturing a broader spectrum of success.
Today, the list is a distinguished editorial award, a celebration of innovation, a network of entrepreneurial leaders, and an effective public relations showcase. The Inc. 500|5000 ranks companies by overall revenue growth over a three-year period. All 5,000 honoree companies are individually profiled on Inc.com. The top 500 are featured in the September issue of Inc. magazine, the leading entrepreneurial advocate for 30 years running. Inc. also ranks the fastest-growing companies by industry, metro area, revenue, and number of employees, and we also highlight women- and minority- run companies.
About Clinipace Worldwide
Clinipace Worldwide, a global digital clinical research organization (dCRO), specializes in fully-integrated clinical research services for biopharmaceutical and medical device firms. Optimized by TEMPO™, its proprietary eClinical platform, the Clinipace team of experts brings extensive knowledge and insight into site selection, patient recruitment, clinical operations, data management, medical monitoring, biostatistics, and regulatory affairs to ensure a successful clinical development program through proactive clinical trial management. With specific expertise in oncology, among other therapeutic areas, Clinipace Worldwide has managed over 90 contract research projects conducted at almost 3,000 sites with 100,000 patients. Clinipace Worldwide is headquartered in Research Triangle Park, NC with additional domestic operations in Overland Park, KS, and South American operations based in Brazil, Argentina, and Peru. For more information visit our website at clinipace.com.